Why do some people with amyloid plaques decline, while others do not? In the May 29 Nature Medicine, researchers led by Tharick Pascoal at the University of Pittsburgh laid some of the blame on reactive astrocytes. Among cognitively healthy people with amyloid...
PITTSBURGH (KDKA) — A study by the University of Pittsburgh claims to have found an earlier detection for people who may have Alzheimer’s, and it used a test many of us routinely take. Blood tests were used to see if someone could develop the...
Tharick Pascoal, MD, PhD (Associate Professor of Psychiatry) is an internationally recognized expert on the imaging and fluid biomarkers of Alzheimer’s disease and related dementias. He recently published two papers examining the multifaceted but interactive...
A blood test that can detect people at early risk of Alzheimer’s is a step closer after scientists implicated a key brain cell in the development of the disease. As well as providing the basis for a test, their work points to a resolution of one of the persistent...
PITTSBURGH — Why do some people develop Alzheimer’s disease while others don’t? And, even more puzzlingly, why do many individuals whose brains are chock-full of toxic amyloid aggregates — a telltale sign of Alzheimer’s brain pathology — never go on to develop...
